The requested information is provided in Portable Document Format (PDF). To view and print this document you'll need to install a copy of the free Adobe® Acrobat® Reader®. If you already have Adobe Acrobat Reader installed click "View PDF" below. If you need the Acrobat Reader you can download it from the Adobe Acrobat Reader Download page.
Duramed Pharmaceuticals, Inc. ("Duramed") respects your privacy, and the privacy of all visitors to its Web sites (the "Sites"). It is the company's policy to collect only personally identifiable information, such as names, addresses, telephone/fax numbers, or email addresses, when such information is voluntarily submitted by our visitors. This information will be kept strictly confidential and will not be sold, reused, rented, loaned, or otherwise disclosed, except as described in this privacy policy.
We will not disclose your information other than to our contractors, where necessary, to operate and maintain this Web site or as required by law or legal process.
We will only use the information we collect from you to answer any of your requests for information, such as to send you updates or other informational mailings you may find useful, or to better understand your needs.
If you decide that you no longer wish to receive informational mailings from this Web site, click here to be removed from our contact list.
Tracking Technology ("Cookies")
Cookies are small text files that are sent by a Web site, accepted by a Web browser, and then placed on your hard drive. Duramed Web sites may use cookies to collect data that help provide information regarding the functionality of the site or to help analyze browsing patterns and use of the site.
Children
The Sites are not intended or designed to attract children under the age of 18. Duramed does not collect personally identifiable data from any person we know to be under the age of 18.
Revisions to This Policy
Duramed reserves the right, at our discretion, to change, modify, add, or remove portions of this policy at any time. If we change our Privacy Policy, we will post those changes on this page so that you may become aware of what information we may collect, how we may use it, and under what circumstances we may disclose it. You should visit this page from time to time to review the then-current policy because it is binding on you. This Privacy Policy was last updated June 2003.
General
Links from these Sites may take you to sites not covered by this Privacy Policy, and we advise you to check the applicable privacy practices yourself.
 |
       
|
 |
Taking ENJUVIA® You should take ENJUVIA once a day, at the same time each day. You can take it with or without food. Taking ENJUVIA may help relieve moderate-to-severe vasomotor symptoms—also known as as hot flashes and night sweats—which are associated with menopause. If you have not had a hysterectomy (which means you still have your uterus), your healthcare professional may also prescribe a second hormone, called a progestin. The progestin prevents an overgrowth of cells in the lining of the uterus. This type of overgrowth increases your risk of uterine cancer. ENJUVIA should not be used if you have or had any of these conditions:
Ask your healthcare professional if ENJUVIA is right for you. IMPORTANT SAFETY INFORMATION Important Information: ENJUVIA is a medicine that contains estrogen hormones. It is prescribed for relief of moderate-to-severe symptoms (hot flashes and night sweats) associated with menopause. Important health information you should know when taking estrogens like ENJUVIA: Estrogens increase the risk for cancer of the uterus (womb). If you experience persistent or recurring vaginal bleeding while taking estrogens let your doctor know right away, as this could be a warning sign for cancer. Your doctor should check for the cause of any unusual vaginal bleeding after menopause. Estrogens (alone or in combination with progestins) should not be used to prevent heart disease, heart attacks, strokes or dementia. Estrogens (alone or in combination with progestins) may increase the risk of heart attack, stroke, blood clots, breast cancer and dementia. Because of these risks, estrogens should be used at the lowest dose for the shortest period of time. You and your doctor should talk regularly to determine whether you still need treatment with ENJUVIA. Who should not use ENJUVIA? Do not use ENJUVIA if you:
— may be pregnant What are the common side effects with ENJUVIA? You may experience headache, breast pain, irregular vaginal bleeding or spotting, stomach/abdominal cramps and bloating, nausea and vomiting, or hair loss. |
 |
